Filing Details

Accession Number:
0000711377-19-000002
Form Type:
4
Zero Holdings:
No
Publication Time:
2019-02-01 08:47:15
Reporting Period:
2019-01-30
Accepted Time:
2019-02-01 08:47:15
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
711377 Neogen Corp NEOG In Vitro & In Vivo Diagnostic Substances (2835) 382367843
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1168789 L James Herbert Neogen Corp
620 Lesher Place
Lansing MI 48912
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2019-01-30 10,000 $59.08 393,035 No 4 S Indirect See Footnote
Common Stock Disposition 2019-01-30 13,419 $59.04 379,616 No 4 S Indirect See footnote
Common Stock Disposition 2019-01-31 5,981 $59.34 373,635 No 4 S Indirect See footnote
Common Stock Disposition 2019-01-31 20,000 $59.73 706,484 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect See Footnote
No 4 S Indirect See footnote
No 4 S Indirect See footnote
No 4 S Direct
Footnotes
  1. The 10,00 shares sold on 1/30 were sold out of a charitable remainder trust in which Mr. Herbert and his spouse are beneficiaries and trustees; 88,783 shares remain in the trust. Mrs. Herbert sold 19,400 shares out of her trust and now holds 124,880 shares in the trust. The remaining shares held indirectly are held in limited liability companies in which Mr. Herbert and his spouse have minority financial position.